Abstract

Author SummarySpinal cord injury is an important cause of disability in young adults, and stem cells have been proposed as a possible treatment. Here we systematically assess the evidence in the scientific literature for the effectiveness of stem-cell–based therapies in animal models of spinal cord injury. More studies reported effects on the ability to move (“motor outcomes”) than on sensation (“sensory outcomes”). Overall, treatment improves both sensory and motor outcomes, and for sensory outcome there was a dose–response effect (which suggests an underlying biological basis). Although more measures were taken to reduce the risk of bias than in other areas of translational neuroscience, unblinded studies tended to overstate the effectiveness of the treatment. The variability observed between the studies is not explained by differences in the stem cells used, but does seem to depend on the different injury models used to emulate human spinal cord injury. This suggests that the mechanism of injury should be an important consideration in the design of future clinical trials. Furthermore, open questions arise about the use of immunosuppressive drugs, and efficacy in female animals; these should be addressed before proceeding to clinical trial.

Highlights

  • Stem cells, from which all tissues can be generated, offer the potential to reconstitute tissues damaged by injury and disease

  • Spinal cord injury is an important cause of disability in young adults, and stem cells have been proposed as a possible treatment

  • We systematically assess the evidence in the scientific literature for the effectiveness of stem-cell–based therapies in animal models of spinal cord injury

Read more

Summary

Introduction

From which all tissues can be generated, offer the potential to reconstitute tissues damaged by injury and disease Realising this potential will demand a detailed knowledge of the genetic and internal environmental cues that specify a cell’s type, location, and interaction with its neighbours. It will require a thorough understanding of stem cell behaviour in the context of lesioned or damaged tissues. Stem cell transplantation was pioneered in the 1950s using haematopoietic stem cells to repopulate the bone marrow in patients with cancers of the blood and bone marrow [1]. Lineage-specific stem cells have been reported to show efficacy in the regeneration of craniofacial bones [15] and of damaged cornea [5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call